External quality assurance schemes (EQUASs) and interlaboratory comparison investigations (ICIs) for the human biomonitoring of aromatic amines in urine as part of the quality assurance programme under HBM4EU

Stefanie Nübler, Therese Burkhardt, Moritz Schäfer, Johannes Müller, Karin Haji-Abbas-Zarrabi, Nikola Pluym, Max Scherer, Gerhard Scherer, Marta Esteban-López, Argelia Castaño, Hans G.J. Mol, Holger M. Koch, Jean Philippe Antignac, Jana Hajslova, Katrin Vorkamp, Thomas Göen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Exposure to aromatic amines may occur via tobacco smoke, hair dyes or tattoo inks, but also in the workplace during certain manufacturing processes. As some aromatic amines are known or suspected carcinogens, human biomonitoring (HBM) is essential to assess their exposure. Aromatic amines were among the selected chemicals in HBM4EU, a European-wide project to harmonise and advance HBM within 30 European countries. For this purpose, the analytical comparability and accuracy of participating laboratories were assessed by a QA/QC programme comprising interlaboratory comparison investigations (ICIs) and external quality assurance schemes (EQUASs). This paper presents the evaluation process and discusses the results of three ICI/EQUAS rounds for the determination of aromatic amines in urine conducted in 2019 and 2020. The final evaluation included ten participants which analysed the following six targeted aromatic amines over three rounds: aniline, ortho-toluidine (TOL), 4,4′-methylenedianiline (MDA), 4,4′-methylenebis(2-chloroaniline) (MOCA), 2,4-diaminotoluene (2,4-TDA), and 2,6-diaminotoluene (2,6-TDA). Most participants achieved satisfactory and highly comparable results, although low quantification limits were required to quantify the parameters at the level of exposure in the general population. Hydrolysis of the sample followed by liquid-liquid extraction and subsequent analysis of the derivatised analytes by means of GC-MS/MS were preferred for the sensitive and precise determination of aromatic amines in urine. This QA/QC programme succeeded in establishing a network of laboratories with high analytical comparability and accuracy for the analysis of aromatic amines in Europe.

Original languageEnglish
Pages (from-to)193-201
Number of pages9
JournalAnalytical Methods
Volume17
Issue number1
Early online date12 Nov 2024
DOIs
Publication statusPublished - 2025

Fingerprint

Dive into the research topics of 'External quality assurance schemes (EQUASs) and interlaboratory comparison investigations (ICIs) for the human biomonitoring of aromatic amines in urine as part of the quality assurance programme under HBM4EU'. Together they form a unique fingerprint.

Cite this